Immunotech-B (06978) announced interim results
- Net profitRMB-69.9M
- Profit attributable to ownersRMB-69.9M
- Net profit YoY+45.8%
- Depreciation & amortisationHK$55.3M
- Capital expenditureHK$-14.6M
- Interest-bearing debtHK$1.0bn
Source Immunotech-B
Source Immunotech-B

